What is he best known for?
The fields of study he is best known for:
- Enzyme
- Organic chemistry
- Catalysis
His primary areas of investigation include Biochemistry, IC50, Antioxidant, Acetylcholinesterase and Pharmacology.
Biochemistry is closely attributed to Selenium in his study.
His work is dedicated to discovering how IC50, Aché are connected with Tacrine, Cholinesterase and Berberine and other disciplines.
His research investigates the connection between Antioxidant and topics such as Clioquinol that intersect with issues in Pharmacophore, Neuroprotection and Protein aggregation.
Specifically, his work in Acetylcholinesterase is concerned with the study of Butyrylcholinesterase.
His Trolox study which covers Combinatorial chemistry that intersects with Resveratrol.
His most cited work include:
- Design, Synthesis, and Evaluation of Multitarget-Directed Resveratrol Derivatives for the Treatment of Alzheimer’s Disease (146 citations)
- Synthesis and Evaluation of Multi-Target-Directed Ligands against Alzheimer's Disease Based on the Fusion of Donepezil and Ebselen (109 citations)
- Multitarget-Directed Benzylideneindanone Derivatives: Anti-β-Amyloid (Aβ) Aggregation, Antioxidant, Metal Chelation, and Monoamine Oxidase B (MAO-B) Inhibition Properties against Alzheimer’s Disease (103 citations)
What are the main themes of his work throughout his whole career to date?
Xingshu Li mostly deals with Catalysis, Biochemistry, Organic chemistry, Stereochemistry and IC50.
His work deals with themes such as Medicinal chemistry, Chirality and Polymer chemistry, which intersect with Catalysis.
He frequently studies issues relating to Clioquinol and Biochemistry.
His study in Stereochemistry is interdisciplinary in nature, drawing from both Design synthesis, Peroxide and Pyridine.
His IC50 study integrates concerns from other disciplines, such as Acetylcholinesterase, Aché, Matrix metalloproteinase and Pharmacology.
His research in Aché intersects with topics in Cholinesterase and Tacrine.
He most often published in these fields:
- Catalysis (32.23%)
- Biochemistry (27.27%)
- Organic chemistry (28.10%)
What were the highlights of his more recent work (between 2017-2021)?
- Biochemistry (27.27%)
- Apoptosis (9.92%)
- Intracellular (7.44%)
In recent papers he was focusing on the following fields of study:
Xingshu Li spends much of his time researching Biochemistry, Apoptosis, Intracellular, IC50 and Pharmacology.
His work in the fields of Biochemistry, such as In vitro, intersects with other areas such as Linker.
The Apoptosis study combines topics in areas such as HeLa, Selenium and Membrane potential.
Xingshu Li has included themes like Acetylcholinesterase, Aché, Epidermal growth factor receptor, Chelation and Pyrimidine in his IC50 study.
Xingshu Li combines subjects such as Design synthesis, Stereochemistry and Tacrine with his study of Aché.
The Pharmacodynamics, Oral administration, Pharmacokinetics and Bioavailability research he does as part of his general Pharmacology study is frequently linked to other disciplines of science, such as Inhibitory postsynaptic potential, therefore creating a link between diverse domains of science.
Between 2017 and 2021, his most popular works were:
- Design, Synthesis, and Evaluation of Orally Bioavailable Quinoline–Indole Derivatives as Innovative Multitarget-Directed Ligands: Promotion of Cell Proliferation in the Adult Murine Hippocampus for the Treatment of Alzheimer’s Disease (32 citations)
- Synthesis and evaluation of clioquinol-rolipram/roflumilast hybrids as multitarget-directed ligands for the treatment of Alzheimer's disease. (18 citations)
- Expression of Insulin-Like Growth Factor Binding Protein-5 (IGFBP5) Reverses Cisplatin-Resistance in Esophageal Carcinoma (15 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Organic chemistry
- Catalysis
Cell growth, In vitro, Biochemistry, Intracellular and Pharmacology are his primary areas of study.
His In vitro study combines topics in areas such as Apoptosis, Cell, Oxygen radical absorbance capacity and Antimitotic Agent.
His study deals with a combination of Biochemistry and Histone deacetylase.
His Intracellular research is multidisciplinary, relying on both Rolipram, Phosphodiesterase, Clioquinol and Antioxidant capacity.
His work is connected to Oral administration, Pharmacokinetics, Bioavailability, Neuroprotection and Pharmacodynamics, as a part of Pharmacology.
Many of his studies on Oral administration involve topics that are commonly interrelated, such as Antioxidant.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
